Stress-activated protein kinase/c-Jun N-terminal kinase (JNK) plays a part in endothelin-1-induced vascular endothelial growth factor synthesis in osteoblasts

Journal of Cellular Biochemistry

Volumn 87, Issue 4, 2002, Pages 417-423

  Wang, Xiaodan ^a   Tokuda, Haruhiko ^b   Hirade, Kouseki ^a   Kozawa, Osamu ^a  

^a GIFU UNIVERSITY   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

Author keywords

ET 1; JNK; VEGF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P42; PROTEIN P44; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VASCULOTROPIN; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ENDOTHELIAL CELL GROWTH FACTOR; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; LYMPHOKINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; BIOSYNTHESIS; BONE; CYTOLOGY; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TIME;

ANIMALS; ANTHRACENES; BONE AND BONES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIN-1; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMIDAZOLES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOKINES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036033816     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10323     Document Type: Article

References (35)

1. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal Kinase. Proc Natl Acad Sci USA 98:13681-13686.
2. Berti-Mattera LN, Wilkins PL, Harwalkar S, Madhun Z, Almhanna K, Mattera R. 2000. Endothelins regulate arachidonic acid release and mitogen-activated protein kinase activity in Schwann cells. J Neurochem 75:2316-2326.
3. Chevalier D, Thorin E, Allen BG. 2000. Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells. J Pharmacol Toxicol Methods 44:429-439.
4. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
5. Erlebacher A, Filvaroff EH, Girelman SE, Derynck R. 1995. Toward a molecular understanding of skeletal development. Cell 80:371-378.
6. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
7. Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification, and angiogenesis during endochondral bone formation. Nature Med 5:623-628.
8. Goad DL, Rubin J, Wang H, Tashijian AH, Jr., Patterson C. 1996. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 137:2262-2268.
9. 1 in osteoblasts. J Clin Invest 93:2490-2496.
10. Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O, Asano T. 1996. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 glioma cells. J Neurochem 66:946-950.
11. Kawamura H, Otsuka T, Tokuda H, Matsuno H, Niwa M, Matsui N, Uematsu T, Kozawa O. 1999a. Involvement of p42/p44 MAP kinase in endothelin-1-induced interleukin-6 synthesis in osteoblast-like cells. Bone 24:315-320.
12. Kawamura H, Otsuka T, Matsuno H, Niwa M, Matsui N, Kato K, Uematsu T, Kozawa O. 1999b. Endothelin-1 stimulates heat shock protein 27 induction in osteoblasts: Involvement of p38 MAP kinase. Am J Physiol 277: E1046-E1054.
13. 2 in osteoblast-like cells. Exp Cell Res 198:130-134.
14. Kozawa O, Kawamura H, Hatakeyama D, Matsuno H, Uematsu T. 2000. Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: Involvement of p38 mitogen-activated protein kinase. Cell Signal 12:375-380.
15. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Masaki T. 1993. Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrinol Rev 14:256-268.
17. Nemoto S, Sheng Z, Lin A. 1998. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 18:3518-3526.
18. Nijweide PJ, Burger EH, Feyen JHM. 1986. Cells of bone: Proliferation, differentiation, and humoral regulation. Physiol Rev 66:855-886.
19. Nishida E, Gotoh Y. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18:128-131.
20. Pollock DM, Keith TL, Highsmith RF. 1995. Endothelin receptors and calcium signaling. FASEB J 9:1196-1204.
21. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, David RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
22. Sakurai T, Morimoto H, Kasuya Y, Takuwa Y, Nakauchi H, Masaki T, Goto K. 1992. Level of ETB receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. Biochem Biophys Res Commun 186:342-347.
23. Schalaeppi JM, Gutzwiller S, Finlenzeller G, Fournier B. 1997. 1,25-dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res 23:213-229.
24. Semler D, Ohlstein EH, Nambi P, Slater C, Stern PH. 1995. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors. J Pharmacol Exp Ther 272:1052-1058.
25. Stern PH, Tatrai A, Semler DE, Lee SK, Lakatos P, Strieleman PJ, Tarjan G, Sanders JL. 1995. Endothelin receptors, second messengers, and actions in bone. J Nutr 125:2028S-2032S.
26. Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S. 1983. In vivo differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198.
27. Suzuki A, Oiso Y, Kozawa O. 1994. Effect of endothelin-1 on phospholipase D activity in osteoblast-like cells. Mol Cell Endocrinol 105:193-196.
28. 2+ from extra- and intracellular pools in osteoblastic cells. Am J Physiol 257:E797-E803.
29. Takuwa Y, Masaki T, Yamashita K. 1990. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem. Biophys Res Commun 170:998-1005.
30. Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R, Kurabayashi M. 2000. Induction of VEGF gene transcription by IL-1β is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32:1955-1967.
31. Tatrai A, Foster S, Lakatos P, Shankar G, Stern PH. 1992. Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology 131:603-607.
32. Tatrai A, Lakatos P, Thompson S, Stern PH. 1992. Effects of endothelin-1 on signal transduction in UMR-106 osteoblastic cells. J Bone Miner Res 7:1201-1209.
33. Wang DS, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K. 1996. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 11:472-479.
34. Widmann C, Gibson S, Jarpe MB, Johnson GL. 1999. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180.
35. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastgenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.